🇺🇸 Immunovant, Inc.
Forum topic · IMVT · Company page: financials, ownership and filings
Join the discussion on Immunovant, Inc.
Loading…
Results announced on 9 November 2026
Immunovant, Inc. announced results on 9 November 2026 (SEC Form 8-K, item 2.02).
For the quarter ended 30 September 2026: a net loss of $97 million.
Insider trading in October 2026
Directors and officers of Immunovant, Inc. reported open-market trades for October 2026 (SEC Forms 4 and 5): 5 insiders sold shares worth about $619,467 in 7 trades.
Awards, option exercises and shares withheld for tax are not counted.
Mutual funds: 167 funds hold $1.3 billion
167 mutual funds in 2 countries hold shares of Immunovant, Inc. worth $1.3 billion, about 16.4% of the company (funds' newest reports, up to 31 July 2026).
Since their previous reports 102 funds added shares and 50 sold; on balance they bought $22 million. Share splits are not counted as trading.
Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.